Table 2.
Univariate and multivariate Cox proportional hazards regression analyses for overall survival.
| Variable | Univariate | Multivariate adjusted* | ||
|---|---|---|---|---|
| HR (95% CI) | p-value | HR (95% CI) | p-value | |
| Treatment type | ||||
| Non-RT and non-surgery | Ref | Ref | ||
| RT | 0.68 (0.58–0.79) | <0.001 | 0.77 (0.66–0.89) | <0.001 |
| Surgery | 0.31 (0.30–0.33) | <0.001 | 0.52 (0.48–0.56) | <0.001 |
| RT and surgery | 0.27 (0.25–0.29) | <0.001 | 0.42 (0.38–0.46) | <0.001 |
| Age | ||||
| <70 | Ref | Ref | ||
| ≥70 | 1.33 (1.27–1.40) | <0.001 | 1.42 (1.35–1.49) | <0.001 |
| Sex | ||||
| Female | Ref | Ref | ||
| Male | 1.04 (0.99–1.10) | 0.126 | 1.10 (1.04–1.16) | <0.001 |
| Year of diagnosis | ||||
| 2004–2009 | Ref | Ref | ||
| 2010–2015 | 0.96 (0.91–1.00) | 0.069 | 0.95 (0.90–1.00) | 0.047 |
| Marital status | ||||
| Married | Ref | Ref | ||
| Others | 1.16 (1.10–1.21) | <0.001 | 1.18 (1.12–1.24) | <0.001 |
| Race | ||||
| White | Ref | Ref | ||
| Others | 1.01 (0.95–1.07) | 0.782 | 1.02 (0.96–1.08) | 0.517 |
| Stage | ||||
| Localized | Ref | Ref | ||
| Regional | 2.34 (2.18–2.50) | <0.001 | 2.41 (2.24–2.59) | <0.001 |
| Distant | 4.13 (3.88–4.39) | <0.001 | 3.66 (3.40–3.94) | <0.001 |
| Grade | ||||
| I | Ref | Ref | ||
| II | 1.52 (1.39–1.67) | <0.001 | 1.36 (1.24–1.49) | <0.001 |
| III | 2.43 (2.22–2.67) | <0.001 | 1.85 (1.68–2.03) | <0.001 |
| IV | 2.51 (2.09–3.00) | <0.001 | 1.94 (1.61–2.33) | <0.001 |
| Unknown | 3.13 (2.85–3.44) | <0.001 | 1.43 (1.29–1.58) | <0.001 |
| Tumor size | ||||
| <5 cm | Ref | Ref | ||
| ≥5 cm | 1.76 (1.64–1.89) | <0.001 | 1.29 (1.20–1.39) | <0.001 |
| Unknown | 1.82 (1.72–1.92) | <0.001 | 1.36 (1.29–1.44) | <0.001 |
| Chemotherapy | ||||
| No/Unknown | Ref | Ref | ||
| Yes | 1.17 (1.11–1.22) | <0.001 | 0.69 (0.65–0.74) | <0.001 |
HR, hazard ratio; CI, confidence interval; RT, radiotherapy; Ref, reference.
The hazard ratio (HR) and 95% confidence interval (CI) were calculated for survival status with respect to treatment status using Cox proportional hazards models. Both non-adjusted and multivariate-adjusted models were implemented.
*Adjusted for age, sex, year of diagnosis, marital status, race, stage, grade, tumor size, and chemotherapy status.